Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Biologic Products Holdings Inc.

www.chinabiologic.com

Latest From China Biologic Products Holdings Inc.

Oncology Dominates As China Drug, Biologic Approvals Surge

China saw a 150% increase in new drug approval applications in 2018, with oncology taking the lion's share of investigational new drug filings, notes a newly released annual report from China’s Center for Drug Evaluation. Meanwhile Darzalex has become the latest foreign drug to be approved.

China Approvals

Hot And Hotter: Lepu Takes $140m Leap Into China Immuno-Oncology Fray

Established just a year ago, China's Lepu Biotech has raised a mighty $131m to develop immuno-oncology antibodies, while Shanghai-based Asieris has obtained worldwide rights to develop and commercialize Photocure's Cevira for cervical dysplasia.

China ImmunoOncology

Re-Listing Still The Best Option For Chinese Life Sciences Firms?

There has been a trend for US-listed Chinese life sciences and health care companies to go private and eventually relist back home. But this process is not only becoming increasingly cumbersome, there is a lot more to worry about than just getting a higher valuation, insiders tell PharmAsia News.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, July 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • China Biologic Products Inc.
  • Shepherd Food Equipment Inc.
  • GRC Holdings Inc
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • China Biologic Products Holdings Inc.
  • Senior Management
  • Joseph Chow , CEO
    Ming Yang, CFO
  • Contact Info
  • China Biologic Products Holdings Inc.
    Phone: 10-6598-3099
    19 Chaoyang Pk, Rd., Jialong Intl. Bldg.
    Rm. 1801
    Beijing , 100125
    China
UsernamePublicRestriction

Register